University of Ioannina
Η δράση διαφόρων φλαβονοειδών και άλλων αντιοξειδωτικών φυτικής προέλευσης στην αιμοπεταλιακή συσσώρευση in vitro και ex vivo
Abstract
dc:descriptionThe aim of the present doctoral thesis was the study of action of the flavonoids quercetin, genistein and apigenin to platelet aggregation, after their activation by adenosine diphosphate (ADP), arachidonate acid and the platelet activating factor (PAF). The platelet reactions where studied in human platelets and in washed rabbit platelets, with both three roots of aggregation open, by an aggregometer. The production of thromboxane Α2 (TXA2) was also studied in the form of its sole product, thromboxane Β2 (ΤΧΒ2). Τhe quantitive determination of TXB2 was defined by using γ-camera and radiolabeled thromboxane antibodies. Finally, it was studied whether the three flavonoids can modulate the presence of fibrinogen receptor GP-IIb-IIIa at the external membrane of human platelets with the use of the proper kit and with flow cytometry. From the present study the results were the following: 1) All three flavonoids used inhibit the platelets aggregation induced by ADP, Arachidonate and PAF. For genistein the sequence of activation is PAF<ADP<arachidonate acid, for apigenin PAF<ADP=arachidonate, while for quercetin PAF<ADP<arachidonate. 2) Both three flavonoids cause dose dependent inhibition of thromboxane Α2 production by the stimulated, of each agonist, human platelets, which is related not only with IC50 of the referred substances but also with the estimated MIC for the corresponding percentage ( 50% and 100%) inhibition of the platelets aggregation. 3) The administration of flavonoids in concentration that causes correspondently 50% and 100% inhibition of platelet aggregation, induces downregulation of the fibrinogen receptors GPIIb-IIIa, that tends to 50% and 100% of their number per platelet.Conclusively, during the flavonoids action, the reduction of TXA2 production act as deceleration or as inhibitor of the platelet’s reactions, and as result the complex of GP IIb-IIIa is dipped in the internal platelet membrane and does not allow the fusion of platelets with the molecules of fibrinogen, and finally among them, so the aggregation and the thrombosis are avoided. If this mechanism can be generalized, the flavonoids can be used pharmaceutical as antiplatelet agents..
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2011
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Θεοχάρης, Βασίλειος
Subjects
dc:subject × 22- Αιμοπετάλια
- Συσσώρευση
- Φλαβονοειδή
- Γενιστεΐνη
- Κονσερσιτίνη
- Παράγοντας ενεργοποίησης αιμοπεταλίων
- Θρομβοξάνη Α₂
- Αντιοξειδωτικά
- Platelets
- Aggregation
- Flavonoids
- Genistein
- Quercetin
- Platelet activating factor (PAF)
- Thromboxane Α₂
- Antioxidants
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Ιατρική Βιοτεχνολογία
- Medical and Health Sciences
- Basic Medicine
- Medical Biotechnology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/34761